USFDA issues import alert for Ranbaxy Mohali facilities
4 просмотров
16.02.2018
00:02:24
Описание
In a major blow to Ranbaxy Laboratories, USFDA has imposed a ban against its Mohali facilities. This ban is likely to impact Ranbaxy's export plans. Mint's CH Unnikrishnan has more on this
Комментарии